Congressman to speak at meeting on diabetes and obesity

September 14, 2010

U.S. Rep. Danny Davis (D-Chicago) will give opening remarks when the Institute of Medicine of the National Academies convenes a regional meeting Sept. 21 at the University of Illinois at Chicago to discuss the rapidly rising rates of diabetes and obesity in the U.S.

"Obesity and diabetes are grave public health issues for our communities, particularly in underserved populations," Davis said. "A recent report found that Illinois was one of eight states with childhood obesity rates greater than 20 percent. With 26.6 percent of our adults obese, Illinois ranked 26 among the nation's heaviest states. Addressing these issues through research, clinical care and community outreach is a top priority for academic institutions such as UIC and other area universities."

The UIC Midwest Conference on Diabetes and Obesity will bring together leading scientists, physicians and community health experts. Causes, treatment, preventive measures and policy issues will be discussed by participants from academia, industry and government. The conference, hosted by the IOM, UIC and the UIC College of Medicine, will be at the UIC Forum, 725. W. Roosevelt Road.

"UIC is proud to co-sponsor this important meeting on a critical health concern," says UIC Chancellor Paula Allen-Meares, who is an elected member of the IOM and chairs a section of its membership committee. "Diabetes has long been a research focus at UIC, where the Chicago Diabetes Project coordinates the research of collaborators on three continents to develop a cell-based therapy to achieve a functional cure. We look forward to the day when this scourge, along with its companion, obesity, is brought under control."

Diabetes is reaching epidemic proportions and may soon become the world's leading cause of death. According to the Chicago Diabetes Project, in 1985 there were 30 million diabetics; today the number has skyrocketed to more than 197 million. By 2025, diabetes is likely to affect more than 300 million people worldwide. The condition leads to serious medical complications including amputations, blindness, kidney failure, heart attacks and stroke. According to the Centers for Disease Control and Prevention, more than 80 percent of people with Type 2 diabetes, the most common form of the disease, are obese or overweight. The two conditions are so strongly associated that decades ago scientists began using the term "diabesity."

The conference's morning session will focus on biomedical advances and prevention of risk. Following a lunch talk about the Chicago Diabetes Project, the afternoon session will address health policy and interventions. The keynote address, by Dr. Jerrold M. Olefsky of the University of California, San Diego, is on genetic and basic studies of the metabolic syndrome in animal models.
-end-
Details of the program and registration are online at tigger.uic.edu/depts/ovcr/research/seminar/IOM/.

The Institute of Medicine is an independent, nonprofit organization that works outside of government to provide unbiased and authoritative advice to decision makers and the public. Established in 1970, the IOM is the health arm of the National Academy of Sciences, which was chartered under President Abraham Lincoln in 1863. Today, the National Academies comprise the National Academy of Sciences, the National Academy of Engineering, the National Research Council, and the IOM.

UIC ranks among the nation's leading research universities and is Chicago's largest university with 27,000 students, 12,000 faculty and staff and15 colleges, including the nation's largest college of medicine. UIC operates the state's major public medical center and has regional health sciences campuses in Peoria, Rockford and Urbana-Champaign. A hallmark of the campus is the Great Cities Commitment, through which UIC faculty, students and staff engage with community, corporate, foundation and government partners in hundreds of programs to improve the quality of life in metropolitan areas around the world.

Major funding for the conference is provided by Dr. Bruce and Marilyn Gillis.

University of Illinois at Chicago

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.